Thrombosthenin is a
Thrombosthenin is a term I remember from platelet function. Wait, isn't it related to the GP IIb/IIIa receptor? That receptor is crucial for platelet aggregation because it binds fibrinogen, allowing platelets to clump together. So thrombosthenin might be another name for that receptor complex. Let me confirm: yes, glycoprotein IIb/IIIa is also called thrombosthenin. So the correct answer should be that it's a platelet membrane glycoprotein complex.
Now, the options. The user didn't provide them, but common distractors could be other platelet components or receptors. For example, maybe options include von Willebrand factor, integrin alpha-IIb beta-3, or something else. The correct answer is the glycoprotein complex. The incorrect options would be other proteins involved in coagulation or platelet function. For each wrong option, I need to explain why they're incorrect. For instance, von Willebrand factor is involved in adhesion, not aggregation. Integrin alpha-IIb beta-3 is the same as GP IIb/IIIa, so if that's a distractor, it's actually correct, but maybe presented differently. Wait, the question is about the name thrombosthenin. So if an option says "integrin receptor," that's the same thing but named differently. But thrombosthenin is specifically the GP IIb/IIIa complex.
Clinical pearl: Thrombosthenin (GP IIb/IIIa) is a target for antiplatelet drugs like abciximab. Patients with Glanzmann's thrombasthenia have defects here, leading to bleeding disorders. That's a high-yield fact for exams.
Putting it all together: The core concept is platelet aggregation mechanism. The correct answer is the glycoprotein complex. Each wrong option is another protein or receptor with different functions. The clinical pearl ties it to drug targets and diseases.
**Core Concept**
Thrombosthenin refers to the **platelet membrane glycoprotein IIb/IIIa complex**, essential for platelet aggregation. This integrin receptor binds fibrinogen, linking adjacent platelets during clot formation. Its dysfunction causes Glanzmann’s thrombasthenia.
**Why the Correct Answer is Right**
Thrombosthenin (GP IIb/IIIa) is a **heterodimeric transmembrane receptor** on platelets. It undergoes conformational changes to bind fibrinogen, enabling platelet-platelet interactions. This is critical for stable clot formation. Inhibitors like abciximab target this receptor to prevent thrombosis.
**Why Each Wrong Option is Incorrect**
**Option A:** *von Willebrand factor* mediates platelet adhesion to subendothelium, not aggregation.
**Option B:** *GP Ib-IX-V complex* binds von Willebrand factor for initial adhesion, unrelated to aggregation.
**Option C:** *Calcium channels* regulate